Finance

Lists
ADCT:NYSE
ADC Therapeutics SA
1,07 USD
-2,73%
(-0,030) 1D
1,07 USD
0,00% (0,00)
After hours
Closed: 5-авг., 16:00:11 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADCT...
Open
1,11 USD
High
1,15 USD
Low
1,07 USD
Mkt. cap
136,09 млн
Avg. vol.
1,25 млн
Volume
970,77 миң
52-wk high
4,98 USD
52-wk low
0,78 USD
EPS
-1,12 USD
Beta
1,89
Shares outstanding
127,19 млн
No. of employees
191
Open
1,11 USD
High
1,15 USD
Low
1,07 USD
Mkt. cap
136,09 млн
Avg. vol.
1,25 млн
Volume
970,77 миң
52-wk high
4,98 USD
52-wk low
0,78 USD
EPS
-1,12 USD
Beta
1,89
Shares outstanding
127,19 млн
No. of employees
191
News stories
From sources across the web
About ADC Therapeutics SA
CEO-
Employees191
Founded2011
Headquarters-
Sector-
Websiteadctherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to ADCT in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ADCT in the last 3 months.
Highest
Current 1,07 USD
10,00 USD (+834,58%)
Average
5,67 USD (+429,91%)
Lowest
2,00 USD (+86,92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Hold
Maintained
2,00 USD
+86,9%
07/07/2026
Michael Schmidt
Guggenheim
Buy
Initiated
10,00 USD
+834,6%
06/30/2026
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
06/08/2026
Sudan Loganathan
Stephens
Buy
Reiterated
5,00 USD
+367,3%
06/04/2026
Last report
2026-ж., 4-май
Fiscal period
Q1 2026
EPS / Est. (USD)
-0,13 USD / -
0,00%miss
Revenue / Est. (USD)
20,85 млн / 19,99 млн
+4,32%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
18,84 млн
16,43 млн
23,06 млн
20,85 млн
Cost of goods sold
30,93 млн
28,00 млн
17,60 млн
23,49 млн
Cost of revenue
30,93 млн
28,00 млн
17,60 млн
23,49 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,97 млн
19,01 млн
21,44 млн
22,60 млн
Operating expense
18,97 млн
19,01 млн
21,44 млн
22,60 млн
Total operating expenses
49,90 млн
47,02 млн
39,04 млн
46,10 млн
Operating income
-31,06 млн
-30,59 млн
-15,98 млн
-25,24 млн
Other non operating income
665,00 миң
587,00 миң
21,84 млн
2,30 млн
EBT including unusual items
-55,39 млн
-40,97 млн
-6,81 млн
-32,97 млн
EBT excluding unusual items
-42,30 млн
-40,59 млн
-4,88 млн
-32,97 млн
Income tax expense
1,25 млн
-
-404,00 миң
-
Effective tax rate
-2,26%
-
5,93%
-
Other operating expenses
-
-
-
-
Net income
-56,65 млн
-40,97 млн
-6,41 млн
-32,97 млн
Net profit margin
-300,68%
-249,38%
-27,80%
-158,11%
Earnings per share
-
-
-
-
Interest and investment income
1,93 млн
2,47 млн
2,35 млн
1,99 млн
Interest expense
-13,00 млн
-13,39 млн
-13,01 млн
-12,35 млн
Net interest expenses
-11,06 млн
-10,92 млн
-10,66 млн
-10,36 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,69 млн
-30,59 млн
-15,98 млн
-25,07 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору